IJSSER

Title: SUPPLY CHAIN DISRUPTION ON MEDICAL COMMODITIES DURING COVID IN INDIA
Authors: Advit Rastogi
\|\| \|\|
Advit Rastogi Delhi Public School R.K. Puram New Delhi
MLA 8 Rastogi, Advit. "SUPPLY CHAIN DISRUPTION ON MEDICAL COMMODITIES DURING COVID IN INDIA." Int. j. of Social Science and Economic Research, vol. 8, no. 1, Jan. 2023, pp. 166-176, doi.org/10.46609/IJSSER.2023.v08i01.011. Accessed Jan. 2023. APA 6 Rastogi, A. (2023, January). SUPPLY CHAIN DISRUPTION ON MEDICAL COMMODITIES DURING COVID IN INDIA. Int. j. of Social Science and Economic Research, 8(1), 166-176. Retrieved from https://doi.org/10.46609/IJSSER.2023.v08i01.011 Chicago Rastogi, Advit. "SUPPLY CHAIN DISRUPTION ON MEDICAL COMMODITIES DURING COVID IN INDIA." Int. j. of Social Science and Economic Research 8, no. 1 (January 2023), 166-176. Accessed January, 2023. https://doi.org/10.46609/IJSSER.2023.v08i01.011.
References [1]. Balfour, H. (2020). COVID-19 update: coronavirus and the pharmaceutical supply chain. European Pharmaceutical Review. [2]. Bhattacharya, K., Alam, M. M., & Jaiswal, M. N. (2021). SUPPLY CHAIN DURING COVID-19 PANDEMIC: A SYSTEMATIC REVIEW. [3]. Fernandes, G., Hassan, I., & Sridhar, D. (2022). Building resilient health-care supply chains to manage pandemics in low-and middle-income countries. Bulletin of the World Health Organization, 100(2), 174. [4]. Gereffi, G., Pananond, P., & Pedersen, T. (2022). Resilience decoded: the role of firms, global value chains, and the state in COVID-19 medical supplies. California Management Review, 64(2), 46-70. [5]. Hossain, M. K., Thakur, V., & Mangla, S. K. (2021). Modeling the emergency health-care supply chains: responding to the COVID-19 pandemic. Journal of Business & Industrial Marketing. [6]. Kale, S., Ashtankar, O. M., & Kakade, K. Effect of COVID 19 Pandemic on Operations Management Activities of Indian Companies. [7]. Kilpatrick, J., & Barter, L. (2020). COVID-19: managing supply chain risk and disruption. Deloitte: Toronto, ON, Canada. [8]. Kirkley, J. (2021). Supply chain risk management copes with evolving threats. [9]. Liao, R., & Fan, Z. (2020, April). Supply chains have been upended. Here’s how to make them more resilient. In World Economic Forum (Vol. 6). [10]. Mahajan, K., & Tomar, S. (2021). COVID?19 and supply chain disruption: Evidence from food markets in India. American journal of agricultural economics, 103(1), 35-52. [11]. McDonnell, A., Pisani, E., Singhvi, S., Chalkidou, K., & Yadav, P. (2021). A path to resiliency: Mitigating the impacts of COVID-19 on essential medicines supply chains. CGD Policy Paper, 213. [12]. Miller, F. A., Young, S. B., Dobrow, M., & Shojania, K. G. (2021). Vulnerability of the medical product supply chain: the wake-up call of COVID-19. BMJ quality & safety, 30(4), 331-335. [13]. Okafor, U. G., Olalaye, M. A., Asobara, H. C., & Umeodinka, E. F. (2021). Global impact of COVID-19 pandemic on public health supply chains. Science-Based Approaches to Respond to COVID and Other Public Health Threats, 87. [14]. Raman, S., Patwa, N., Niranjan, I., Ranjan, U., Moorthy, K., & Mehta, A. (2018). Impact of big data on supply chain management. International Journal of Logistics Research and Applications, 21(6), 579-596. [15]. Seth, A. (2021). IMPACT OF COVID-19 ON SUPPLY CHAIN. [16]. Tirivangani, T., Alpo, B., Kibuule, D., Gaeseb, J., & Adenuga, B. A. (2021). Impact of COVID-19 pandemic on pharmaceutical systems and supply chain–a phenomenological study. Exploratory Research in clinical and social pharmacy, 2, 100037. [17]. Tonday, H. R., Katore, P. D., Raut, D. S., Rathod, A. D., & Morwal, A. I. Study of Implementation of Agile Supply Chain For Efficient Delivery of Essentials During Covid-19. [18]. Xu, Z., Elomri, A., Kerbache, L., & El Omri, A. (2020). Impacts of COVID-19 on global supply chains: Facts and perspectives. IEEE Engineering Management Review, 48(3), 153-166. [19]. Zheng, Y., Liu, L., Shi, V., Huang, W., & Liao, J. (2022). A Resilience Analysis of a Medical Mask Supply Chain during the COVID-19 Pandemic: A Simulation Modeling Approach. International Journal of Environmental Research and Public Health, 19(13), 8045. [20]. Zhu, G., Chou, M. C., & Tsai, C. W. (2020). Lessons learned from the COVID-19 pandemic exposing the shortcomings of current supply chain operations: a long-term prescriptive offering. Sustainability, 12(14), 5858.
ABSTRACT: The interruptions in China had a domino effect on worldwide supply networks before the severe lockdowns were imposed and COVID-19 spread. Priorities have shifted to ensure that expenditures are kept to a minimum and that necessities are delivered on time. Since the epidemic has worsened in India, the logistics supply chain has seen interruptions. The rising demand and decreasing supply may be traced back to a number of causes. Several practical options exist for investigating the current state of affairs. Promoting Indian markets and adjusting policies to aid the local labour force in reducing import dependence on other nations is a priority. The Indian logistics supply chain will benefit from this. This will boost economic growth and job prospects. The objective of the paper states to evaluate supply chain perspective of medical equipment and commodities on India’s covid-19 crisis, to analyse the impact of covid-19 disruptions on the medical commodity supply chain in India and to discuss how healthcare facilities developed resilience and responsiveness towards supply chains of medical commodities post covid in India. The data came in undercover, through a variety of secondary resources. This employs describing and exploring techniques. According to the retracted result, the logistics supply chain is far broader than only the worldwide transport of medications and other products. It deals with problems at the grass-roots level, such the lateness of transporters and couriers and the difficulty of moving people inside industrial units and prohibiting transportation activities (especially trucks). Disruptions in the supply chain affect a wide variety of products, including vaccines, hand sanitizers, testing kits, protected healthcare equipment (PPE), medicines, medical equipment, raw materials, and much more.

IJSSER is Member of